Fenster schließen  |  Fenster drucken

NEWARK, Del,. April 4, 2012 /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO)
today announced issuance of a US patent covering compositions and methods
for generating clonal cell lines and plants for expressing gene products. This
invention, developed by the Fraunhofer USA Center for Molecular Biotechnology,
iBio’s research collaborator, is a part of iBio’s broader iBioLaunch™ platform for
vaccines and therapeutics. The new patent is US Patent 8,148,608 entitled
“Systems and methods for clonal expression in plants.”
 
aus der Diskussion: iBio - Die Impfstoffmaschine
Autor (Datum des Eintrages): lunatics  (09.04.12 10:49:39)
Beitrag: 6 von 18,242 (ID:43015166)
Alle Angaben ohne Gewähr © wallstreetONLINE